Resurgence of Ebola in Uganda: Response Strategies, Lessons Learned, and Future Directions

Abstract

Introduction: The recent resurgence of Ebola virus disease (EVD), specifically the Sudan virus strain, in Uganda highlights the ongoing threat of emerging infectious diseases. This article aims to analyze the multifaceted factors contributing to this resurgence, evaluate the public health impact, and assess the effectiveness of response strategies to derive critical lessons for future pandemic preparedness. Methods: This perspective piece synthesizes existing literature and reports on the recent Sudan virus outbreak in Uganda. It examines viral dynamics, gaps in surveillance and diagnostics, socio‐cultural influences on transmission, and challenges in governmental response. The analysis further evaluates the impact on healthcare systems, healthcare workers, and socioeconomic structures. Response strategies at national, regional, and global levels, including community engagement, are also reviewed to identify key elements of effective control. Results: The resurgence is likely driven by a combination of factors including the lack of a readily available vaccine for the Sudan strain, limitations in early detection and response capacities, socio‐cultural practices influencing transmission, and coordination challenges. The outbreak has strained healthcare resources, posed risks to healthcare workers, and caused socioeconomic disruptions. Effective response strategies have involved early detection, contact tracing, and community engagement, with regional and international collaboration playing a crucial role. Lessons learned emphasize the need for sustained investment in health systems, research and development, and robust community engagement for effective preparedness. Conclusion: The recent Sudan virus outbreak in Uganda underscores the critical need for continuous strengthening of pandemic preparedness and response mechanisms. Future directions should focus on sustainable capacity building, enhanced surveillance and diagnostic capabilities, investment in research for strain‐specific interventions, and collaborative frameworks at all levels to mitigate the impact of future emerging infectious disease threats.